nodes	percent_of_prediction	percent_of_DWPC	metapath
Minocycline—VEGFA—Vandetanib—thyroid cancer	0.754	1	CbGbCtD
Minocycline—CYCS—neck—thyroid cancer	0.00678	0.102	CbGeAlD
Minocycline—CASP3—neck—thyroid cancer	0.00581	0.087	CbGeAlD
Minocycline—CYCS—Afatinib—Vandetanib—thyroid cancer	0.00442	1	CbGdCrCtD
Minocycline—CASP1—trachea—thyroid cancer	0.00424	0.0635	CbGeAlD
Minocycline—MMP9—neck—thyroid cancer	0.00387	0.0579	CbGeAlD
Minocycline—CASP3—trachea—thyroid cancer	0.00349	0.0524	CbGeAlD
Minocycline—CASP1—thyroid gland—thyroid cancer	0.00335	0.0502	CbGeAlD
Minocycline—CYCS—thyroid gland—thyroid cancer	0.00323	0.0484	CbGeAlD
Minocycline—CASP1—head—thyroid cancer	0.00297	0.0446	CbGeAlD
Minocycline—CYCS—head—thyroid cancer	0.00286	0.0429	CbGeAlD
Minocycline—CASP3—thyroid gland—thyroid cancer	0.00276	0.0414	CbGeAlD
Minocycline—VEGFA—trachea—thyroid cancer	0.00275	0.0411	CbGeAlD
Minocycline—CASP3—head—thyroid cancer	0.00245	0.0367	CbGeAlD
Minocycline—IL1B—thyroid gland—thyroid cancer	0.00221	0.0331	CbGeAlD
Minocycline—VEGFA—thyroid gland—thyroid cancer	0.00217	0.0325	CbGeAlD
Minocycline—CASP1—lymph node—thyroid cancer	0.00208	0.0312	CbGeAlD
Minocycline—CYCS—lymph node—thyroid cancer	0.002	0.03	CbGeAlD
Minocycline—IL1B—head—thyroid cancer	0.00196	0.0294	CbGeAlD
Minocycline—CASP3—lymph node—thyroid cancer	0.00172	0.0257	CbGeAlD
Minocycline—MMP9—head—thyroid cancer	0.00163	0.0245	CbGeAlD
Minocycline—ALOX5—thyroid gland—thyroid cancer	0.00145	0.0218	CbGeAlD
Minocycline—IL1B—lymph node—thyroid cancer	0.00137	0.0206	CbGeAlD
Minocycline—VEGFA—lymph node—thyroid cancer	0.00135	0.0202	CbGeAlD
Minocycline—ALOX5—head—thyroid cancer	0.00129	0.0193	CbGeAlD
Minocycline—MMP9—lymph node—thyroid cancer	0.00114	0.0171	CbGeAlD
Minocycline—ALOX5—lymph node—thyroid cancer	0.000904	0.0135	CbGeAlD
Minocycline—SLC22A8—head—thyroid cancer	0.000873	0.0131	CbGeAlD
Minocycline—CASP3—Integrated Pancreatic Cancer Pathway—CCND1—thyroid cancer	0.000137	0.000782	CbGpPWpGaD
Minocycline—CASP3—TNF alpha Signaling Pathway—AKT1—thyroid cancer	0.000136	0.00078	CbGpPWpGaD
Minocycline—CASP3—Corticotropin-releasing hormone—AKT1—thyroid cancer	0.000136	0.00078	CbGpPWpGaD
Minocycline—VEGFA—Integrated Breast Cancer Pathway—BRAF—thyroid cancer	0.000136	0.000779	CbGpPWpGaD
Minocycline—CASP3—Signaling by NGF—BRAF—thyroid cancer	0.000135	0.000776	CbGpPWpGaD
Minocycline—VEGFA—SHP2 signaling—HRAS—thyroid cancer	0.000134	0.00077	CbGpPWpGaD
Minocycline—CASP3—Spinal Cord Injury—TP53—thyroid cancer	0.000132	0.000757	CbGpPWpGaD
Minocycline—CASP3—Integrated Pancreatic Cancer Pathway—PTEN—thyroid cancer	0.000132	0.000755	CbGpPWpGaD
Minocycline—CYCS—Apoptosis—TP53—thyroid cancer	0.000132	0.000754	CbGpPWpGaD
Minocycline—VEGFA—Hemostasis—PRKAR1A—thyroid cancer	0.000132	0.000753	CbGpPWpGaD
Minocycline—IL1B—Senescence and Autophagy in Cancer—TP53—thyroid cancer	0.000131	0.000753	CbGpPWpGaD
Minocycline—CASP3—MAPK Signaling Pathway—NRAS—thyroid cancer	0.00013	0.000746	CbGpPWpGaD
Minocycline—VEGFA—Axon guidance—CDK1—thyroid cancer	0.000129	0.000741	CbGpPWpGaD
Minocycline—VEGFA—Oncostatin M Signaling Pathway—TP53—thyroid cancer	0.000128	0.000735	CbGpPWpGaD
Minocycline—MMP9—Validated targets of C-MYC transcriptional activation—TP53—thyroid cancer	0.000126	0.000725	CbGpPWpGaD
Minocycline—MMP9—Endochondral Ossification—AKT1—thyroid cancer	0.000126	0.000724	CbGpPWpGaD
Minocycline—MMP9—LPA receptor mediated events—AKT1—thyroid cancer	0.000126	0.000724	CbGpPWpGaD
Minocycline—IL1B—Senescence and Autophagy in Cancer—HRAS—thyroid cancer	0.000126	0.00072	CbGpPWpGaD
Minocycline—IL1B—TCR Signaling Pathway—AKT1—thyroid cancer	0.000125	0.000719	CbGpPWpGaD
Minocycline—CASP1—Cytokine Signaling in Immune system—NRAS—thyroid cancer	0.000125	0.000718	CbGpPWpGaD
Minocycline—SLC22A11—Transmembrane transport of small molecules—TPR—thyroid cancer	0.000123	0.000707	CbGpPWpGaD
Minocycline—SLC22A11—Transmembrane transport of small molecules—CP—thyroid cancer	0.000123	0.000707	CbGpPWpGaD
Minocycline—MMP9—AGE/RAGE pathway—AKT1—thyroid cancer	0.000123	0.000707	CbGpPWpGaD
Minocycline—IL1B—Signaling by Interleukins—HRAS—thyroid cancer	0.000123	0.000704	CbGpPWpGaD
Minocycline—VEGFA—Oncostatin M Signaling Pathway—HRAS—thyroid cancer	0.000123	0.000703	CbGpPWpGaD
Minocycline—CASP3—Integrated Breast Cancer Pathway—KRAS—thyroid cancer	0.000122	0.000699	CbGpPWpGaD
Minocycline—CASP1—MAPK Signaling Pathway—AKT1—thyroid cancer	0.000122	0.000698	CbGpPWpGaD
Minocycline—SLC22A11—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	0.000121	0.000696	CbGpPWpGaD
Minocycline—IL1B—Spinal Cord Injury—TP53—thyroid cancer	0.00012	0.000685	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—HPGD—thyroid cancer	0.00012	0.000685	CbGpPWpGaD
Minocycline—IL1B—MAPK Signaling Pathway—NRAS—thyroid cancer	0.000118	0.000675	CbGpPWpGaD
Minocycline—MMP9—Signaling by SCF-KIT—PTEN—thyroid cancer	0.000117	0.000668	CbGpPWpGaD
Minocycline—SLC22A6—SLC-mediated transmembrane transport—SLC5A5—thyroid cancer	0.000116	0.000663	CbGpPWpGaD
Minocycline—CASP1—Immune System—CDK1—thyroid cancer	0.000114	0.000654	CbGpPWpGaD
Minocycline—IL1B—Toll-like Receptor Signaling Pathway—AKT1—thyroid cancer	0.000114	0.00065	CbGpPWpGaD
Minocycline—VEGFA—Focal Adhesion—BRAF—thyroid cancer	0.000113	0.000648	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—CALCB—thyroid cancer	0.000113	0.000646	CbGpPWpGaD
Minocycline—VEGFA—VEGFA-VEGFR2 Pathway—NRAS—thyroid cancer	0.000113	0.000645	CbGpPWpGaD
Minocycline—CASP3—MAPK Signaling Pathway—KRAS—thyroid cancer	0.000112	0.000642	CbGpPWpGaD
Minocycline—SLC22A7—Transmembrane transport of small molecules—TPR—thyroid cancer	0.000112	0.000642	CbGpPWpGaD
Minocycline—SLC22A7—Transmembrane transport of small molecules—CP—thyroid cancer	0.000112	0.000642	CbGpPWpGaD
Minocycline—CYCS—Metabolism—TPR—thyroid cancer	0.000111	0.000639	CbGpPWpGaD
Minocycline—CYCS—Apoptosis—AKT1—thyroid cancer	0.000111	0.000637	CbGpPWpGaD
Minocycline—VEGFA—Integrins in angiogenesis—AKT1—thyroid cancer	0.000111	0.000637	CbGpPWpGaD
Minocycline—SLC22A7—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	0.00011	0.000631	CbGpPWpGaD
Minocycline—CASP1—Immune System—IFNA2—thyroid cancer	0.00011	0.000629	CbGpPWpGaD
Minocycline—VEGFA—Endochondral Ossification—AKT1—thyroid cancer	0.00011	0.000629	CbGpPWpGaD
Minocycline—CYCS—Metabolism—PRKAR1A—thyroid cancer	0.00011	0.000628	CbGpPWpGaD
Minocycline—CASP3—Integrated Breast Cancer Pathway—TP53—thyroid cancer	0.000109	0.000622	CbGpPWpGaD
Minocycline—VEGFA—Oncostatin M Signaling Pathway—AKT1—thyroid cancer	0.000108	0.000621	CbGpPWpGaD
Minocycline—CASP1—Cytokine Signaling in Immune system—KRAS—thyroid cancer	0.000108	0.000618	CbGpPWpGaD
Minocycline—CASP3—BDNF signaling pathway—HRAS—thyroid cancer	0.000108	0.000618	CbGpPWpGaD
Minocycline—VEGFA—HIF-1-alpha transcription factor network—AKT1—thyroid cancer	0.000107	0.000613	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—TRIM33—thyroid cancer	0.000107	0.000612	CbGpPWpGaD
Minocycline—MMP9—Developmental Biology—CDK1—thyroid cancer	0.000106	0.000609	CbGpPWpGaD
Minocycline—VEGFA—Signaling by VEGF—NRAS—thyroid cancer	0.000106	0.000609	CbGpPWpGaD
Minocycline—CASP3—Apoptosis—TP53—thyroid cancer	0.000106	0.000609	CbGpPWpGaD
Minocycline—IL1B—Immune System—TPR—thyroid cancer	0.000105	0.000603	CbGpPWpGaD
Minocycline—MMP9—EPH-Ephrin signaling—HRAS—thyroid cancer	0.000105	0.000603	CbGpPWpGaD
Minocycline—VEGFA—Cellular responses to stress—HIF1A—thyroid cancer	0.000105	0.000602	CbGpPWpGaD
Minocycline—VEGFA—Signaling events mediated by VEGFR1 and VEGFR2—AKT1—thyroid cancer	0.000105	0.000599	CbGpPWpGaD
Minocycline—IL1B—Immune System—LGALS3—thyroid cancer	0.000104	0.000598	CbGpPWpGaD
Minocycline—MMP9—Signaling by SCF-KIT—NRAS—thyroid cancer	0.000104	0.000596	CbGpPWpGaD
Minocycline—IL1B—Immune System—PRKAR1A—thyroid cancer	0.000104	0.000593	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—TCF7L1—thyroid cancer	0.000103	0.000589	CbGpPWpGaD
Minocycline—MMP9—CXCR4-mediated signaling events—AKT1—thyroid cancer	0.000102	0.000583	CbGpPWpGaD
Minocycline—IL1B—MAPK Signaling Pathway—KRAS—thyroid cancer	0.000101	0.000581	CbGpPWpGaD
Minocycline—CASP3—Integrated Pancreatic Cancer Pathway—KRAS—thyroid cancer	0.000101	0.00058	CbGpPWpGaD
Minocycline—CASP3—MAPK Signaling Pathway—TP53—thyroid cancer	9.96e-05	0.000571	CbGpPWpGaD
Minocycline—VEGFA—Integrated Breast Cancer Pathway—CCND1—thyroid cancer	9.93e-05	0.000569	CbGpPWpGaD
Minocycline—MMP9—Developmental Biology—RXRA—thyroid cancer	9.87e-05	0.000566	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—CALCB—thyroid cancer	9.79e-05	0.000561	CbGpPWpGaD
Minocycline—ALOX5—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	9.7e-05	0.000556	CbGpPWpGaD
Minocycline—VEGFA—VEGFA-VEGFR2 Pathway—KRAS—thyroid cancer	9.69e-05	0.000555	CbGpPWpGaD
Minocycline—VEGFA—Integrated Breast Cancer Pathway—PTEN—thyroid cancer	9.58e-05	0.000549	CbGpPWpGaD
Minocycline—CASP3—Signaling by NGF—PTEN—thyroid cancer	9.54e-05	0.000546	CbGpPWpGaD
Minocycline—CASP3—BDNF signaling pathway—AKT1—thyroid cancer	9.52e-05	0.000545	CbGpPWpGaD
Minocycline—SLC22A8—Transmembrane transport of small molecules—CP—thyroid cancer	9.41e-05	0.000539	CbGpPWpGaD
Minocycline—SLC22A8—Transmembrane transport of small molecules—TPR—thyroid cancer	9.41e-05	0.000539	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—TRIM33—thyroid cancer	9.28e-05	0.000532	CbGpPWpGaD
Minocycline—SLC22A8—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	9.26e-05	0.000531	CbGpPWpGaD
Minocycline—SLC22A11—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	9.24e-05	0.000529	CbGpPWpGaD
Minocycline—VEGFA—Developmental Biology—CDK1—thyroid cancer	9.23e-05	0.000529	CbGpPWpGaD
Minocycline—MMP9—Spinal Cord Injury—TP53—thyroid cancer	9.18e-05	0.000526	CbGpPWpGaD
Minocycline—CASP1—Cytokine Signaling in Immune system—HRAS—thyroid cancer	9.17e-05	0.000525	CbGpPWpGaD
Minocycline—CASP3—Integrated Breast Cancer Pathway—AKT1—thyroid cancer	9.16e-05	0.000525	CbGpPWpGaD
Minocycline—CASP1—Immune System—NRG1—thyroid cancer	9.16e-05	0.000525	CbGpPWpGaD
Minocycline—VEGFA—Signaling by VEGF—KRAS—thyroid cancer	9.15e-05	0.000524	CbGpPWpGaD
Minocycline—VEGFA—EPH-Ephrin signaling—HRAS—thyroid cancer	9.14e-05	0.000524	CbGpPWpGaD
Minocycline—VEGFA—Integrated Pancreatic Cancer Pathway—PTGS2—thyroid cancer	9.1e-05	0.000522	CbGpPWpGaD
Minocycline—IL1B—MAPK Signaling Pathway—TP53—thyroid cancer	9.02e-05	0.000517	CbGpPWpGaD
Minocycline—CASP3—Integrated Pancreatic Cancer Pathway—TP53—thyroid cancer	8.99e-05	0.000515	CbGpPWpGaD
Minocycline—CASP3—Apoptosis—AKT1—thyroid cancer	8.97e-05	0.000514	CbGpPWpGaD
Minocycline—MMP9—Signaling by SCF-KIT—KRAS—thyroid cancer	8.95e-05	0.000513	CbGpPWpGaD
Minocycline—IL1B—Regulation of toll-like receptor signaling pathway—AKT1—thyroid cancer	8.86e-05	0.000508	CbGpPWpGaD
Minocycline—VEGFA—Hemostasis—IFNA2—thyroid cancer	8.71e-05	0.000499	CbGpPWpGaD
Minocycline—CYCS—Cellular responses to stress—TP53—thyroid cancer	8.6e-05	0.000493	CbGpPWpGaD
Minocycline—VEGFA—Developmental Biology—RXRA—thyroid cancer	8.57e-05	0.000491	CbGpPWpGaD
Minocycline—CASP3—Signaling by NGF—NRAS—thyroid cancer	8.51e-05	0.000488	CbGpPWpGaD
Minocycline—CASP3—MAPK Signaling Pathway—AKT1—thyroid cancer	8.41e-05	0.000482	CbGpPWpGaD
Minocycline—SLC22A7—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	8.38e-05	0.00048	CbGpPWpGaD
Minocycline—CYCS—Metabolism—SLC5A5—thyroid cancer	8.34e-05	0.000478	CbGpPWpGaD
Minocycline—VEGFA—Focal Adhesion—CCND1—thyroid cancer	8.26e-05	0.000473	CbGpPWpGaD
Minocycline—VEGFA—VEGFA-VEGFR2 Pathway—HRAS—thyroid cancer	8.24e-05	0.000472	CbGpPWpGaD
Minocycline—VEGFA—Integrated Pancreatic Cancer Pathway—CCND1—thyroid cancer	8.23e-05	0.000471	CbGpPWpGaD
Minocycline—VEGFA—Focal Adhesion—PTEN—thyroid cancer	7.97e-05	0.000457	CbGpPWpGaD
Minocycline—VEGFA—Integrated Pancreatic Cancer Pathway—PTEN—thyroid cancer	7.94e-05	0.000455	CbGpPWpGaD
Minocycline—CASP1—Innate Immune System—PTEN—thyroid cancer	7.88e-05	0.000451	CbGpPWpGaD
Minocycline—SLC22A6—Transmembrane transport of small molecules—CP—thyroid cancer	7.86e-05	0.00045	CbGpPWpGaD
Minocycline—SLC22A6—Transmembrane transport of small molecules—TPR—thyroid cancer	7.86e-05	0.00045	CbGpPWpGaD
Minocycline—IL1B—Cytokine Signaling in Immune system—NRAS—thyroid cancer	7.83e-05	0.000449	CbGpPWpGaD
Minocycline—VEGFA—Signaling by VEGF—HRAS—thyroid cancer	7.78e-05	0.000446	CbGpPWpGaD
Minocycline—SLC22A11—Transmembrane transport of small molecules—RXRA—thyroid cancer	7.76e-05	0.000445	CbGpPWpGaD
Minocycline—SLC22A6—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	7.73e-05	0.000443	CbGpPWpGaD
Minocycline—IL1B—MAPK Signaling Pathway—AKT1—thyroid cancer	7.62e-05	0.000436	CbGpPWpGaD
Minocycline—MMP9—Signaling by SCF-KIT—HRAS—thyroid cancer	7.61e-05	0.000436	CbGpPWpGaD
Minocycline—CASP3—Integrated Pancreatic Cancer Pathway—AKT1—thyroid cancer	7.59e-05	0.000435	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—TSHR—thyroid cancer	7.52e-05	0.000431	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—PRKAR1A—thyroid cancer	7.4e-05	0.000424	CbGpPWpGaD
Minocycline—VEGFA—Integrated Breast Cancer Pathway—KRAS—thyroid cancer	7.36e-05	0.000422	CbGpPWpGaD
Minocycline—CASP3—Signaling by NGF—KRAS—thyroid cancer	7.32e-05	0.00042	CbGpPWpGaD
Minocycline—VEGFA—VEGFA-VEGFR2 Pathway—AKT1—thyroid cancer	7.27e-05	0.000417	CbGpPWpGaD
Minocycline—IL1B—Immune System—CDK1—thyroid cancer	7.13e-05	0.000409	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—TCF7L1—thyroid cancer	7.13e-05	0.000409	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—MEN1—thyroid cancer	7.07e-05	0.000405	CbGpPWpGaD
Minocycline—SLC22A8—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	7.05e-05	0.000404	CbGpPWpGaD
Minocycline—SLC22A7—Transmembrane transport of small molecules—RXRA—thyroid cancer	7.04e-05	0.000404	CbGpPWpGaD
Minocycline—CASP1—Innate Immune System—NRAS—thyroid cancer	7.03e-05	0.000403	CbGpPWpGaD
Minocycline—CYCS—Metabolism—RXRA—thyroid cancer	7.01e-05	0.000402	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—TPR—thyroid cancer	6.87e-05	0.000393	CbGpPWpGaD
Minocycline—VEGFA—Signaling by VEGF—AKT1—thyroid cancer	6.87e-05	0.000393	CbGpPWpGaD
Minocycline—IL1B—Immune System—IFNA2—thyroid cancer	6.86e-05	0.000393	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—PRKAR1A—thyroid cancer	6.76e-05	0.000387	CbGpPWpGaD
Minocycline—IL1B—Cytokine Signaling in Immune system—KRAS—thyroid cancer	6.74e-05	0.000386	CbGpPWpGaD
Minocycline—MMP9—Signaling by SCF-KIT—AKT1—thyroid cancer	6.72e-05	0.000385	CbGpPWpGaD
Minocycline—VEGFA—Integrated Breast Cancer Pathway—TP53—thyroid cancer	6.54e-05	0.000375	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—PTCH1—thyroid cancer	6.39e-05	0.000366	CbGpPWpGaD
Minocycline—MMP9—Developmental Biology—PPARG—thyroid cancer	6.23e-05	0.000357	CbGpPWpGaD
Minocycline—CASP3—Signaling by NGF—HRAS—thyroid cancer	6.23e-05	0.000357	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—TCF7L1—thyroid cancer	6.19e-05	0.000355	CbGpPWpGaD
Minocycline—ALOX5—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	6.12e-05	0.000351	CbGpPWpGaD
Minocycline—VEGFA—Integrated Pancreatic Cancer Pathway—KRAS—thyroid cancer	6.1e-05	0.000349	CbGpPWpGaD
Minocycline—CASP1—Innate Immune System—KRAS—thyroid cancer	6.05e-05	0.000347	CbGpPWpGaD
Minocycline—SLC22A8—Transmembrane transport of small molecules—RXRA—thyroid cancer	5.92e-05	0.000339	CbGpPWpGaD
Minocycline—SLC22A6—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	5.88e-05	0.000337	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—SST—thyroid cancer	5.85e-05	0.000335	CbGpPWpGaD
Minocycline—IL1B—Cytokine Signaling in Immune system—HRAS—thyroid cancer	5.73e-05	0.000328	CbGpPWpGaD
Minocycline—IL1B—Immune System—NRG1—thyroid cancer	5.73e-05	0.000328	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—CALCA—thyroid cancer	5.63e-05	0.000323	CbGpPWpGaD
Minocycline—VEGFA—Integrated Breast Cancer Pathway—AKT1—thyroid cancer	5.52e-05	0.000316	CbGpPWpGaD
Minocycline—CASP3—Signaling by NGF—AKT1—thyroid cancer	5.5e-05	0.000315	CbGpPWpGaD
Minocycline—VEGFA—Integrated Pancreatic Cancer Pathway—TP53—thyroid cancer	5.42e-05	0.00031	CbGpPWpGaD
Minocycline—VEGFA—Developmental Biology—PPARG—thyroid cancer	5.41e-05	0.00031	CbGpPWpGaD
Minocycline—MMP9—Axon guidance—NRAS—thyroid cancer	5.35e-05	0.000306	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—TSHR—thyroid cancer	5.22e-05	0.000299	CbGpPWpGaD
Minocycline—VEGFA—Focal Adhesion—HRAS—thyroid cancer	5.2e-05	0.000298	CbGpPWpGaD
Minocycline—CASP1—Innate Immune System—HRAS—thyroid cancer	5.14e-05	0.000295	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—SLC5A5—thyroid cancer	5.14e-05	0.000295	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—PRKAR1A—thyroid cancer	5.14e-05	0.000294	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—CDK1—thyroid cancer	5.1e-05	0.000292	CbGpPWpGaD
Minocycline—SLC22A6—Transmembrane transport of small molecules—RXRA—thyroid cancer	4.94e-05	0.000283	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—MEN1—thyroid cancer	4.91e-05	0.000281	CbGpPWpGaD
Minocycline—ALOX5—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	4.82e-05	0.000276	CbGpPWpGaD
Minocycline—VEGFA—Axon guidance—NRAS—thyroid cancer	4.64e-05	0.000266	CbGpPWpGaD
Minocycline—MMP9—Axon guidance—KRAS—thyroid cancer	4.6e-05	0.000264	CbGpPWpGaD
Minocycline—VEGFA—Focal Adhesion—AKT1—thyroid cancer	4.6e-05	0.000263	CbGpPWpGaD
Minocycline—CASP1—Immune System—PTEN—thyroid cancer	4.59e-05	0.000263	CbGpPWpGaD
Minocycline—VEGFA—Integrated Pancreatic Cancer Pathway—AKT1—thyroid cancer	4.58e-05	0.000262	CbGpPWpGaD
Minocycline—CASP1—Innate Immune System—AKT1—thyroid cancer	4.54e-05	0.00026	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—TSHR—thyroid cancer	4.53e-05	0.00026	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—PRKAR1A—thyroid cancer	4.46e-05	0.000255	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—PTCH1—thyroid cancer	4.44e-05	0.000254	CbGpPWpGaD
Minocycline—CYCS—Metabolism—PPARG—thyroid cancer	4.43e-05	0.000254	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—RXRA—thyroid cancer	4.32e-05	0.000247	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—MEN1—thyroid cancer	4.26e-05	0.000244	CbGpPWpGaD
Minocycline—ALOX5—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	4.2e-05	0.000241	CbGpPWpGaD
Minocycline—VEGFA—Cellular responses to stress—TP53—thyroid cancer	4.18e-05	0.00024	CbGpPWpGaD
Minocycline—CASP1—Immune System—NRAS—thyroid cancer	4.09e-05	0.000235	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—NRG1—thyroid cancer	4.09e-05	0.000234	CbGpPWpGaD
Minocycline—VEGFA—Platelet activation, signaling and aggregation—AKT1—thyroid cancer	4.07e-05	0.000233	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—SST—thyroid cancer	4.06e-05	0.000233	CbGpPWpGaD
Minocycline—VEGFA—Axon guidance—KRAS—thyroid cancer	3.99e-05	0.000229	CbGpPWpGaD
Minocycline—MMP9—Axon guidance—HRAS—thyroid cancer	3.91e-05	0.000224	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—CALCA—thyroid cancer	3.91e-05	0.000224	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—PTCH1—thyroid cancer	3.85e-05	0.000221	CbGpPWpGaD
Minocycline—MMP9—Developmental Biology—NRAS—thyroid cancer	3.82e-05	0.000219	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—TERT—thyroid cancer	3.67e-05	0.00021	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—CDK1—thyroid cancer	3.54e-05	0.000203	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—SST—thyroid cancer	3.52e-05	0.000202	CbGpPWpGaD
Minocycline—CASP1—Immune System—KRAS—thyroid cancer	3.52e-05	0.000202	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—HIF1A—thyroid cancer	3.51e-05	0.000201	CbGpPWpGaD
Minocycline—CYCS—Metabolism—PTGS2—thyroid cancer	3.48e-05	0.000199	CbGpPWpGaD
Minocycline—VEGFA—Axon guidance—HRAS—thyroid cancer	3.4e-05	0.000195	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—CALCA—thyroid cancer	3.39e-05	0.000194	CbGpPWpGaD
Minocycline—VEGFA—Developmental Biology—NRAS—thyroid cancer	3.31e-05	0.00019	CbGpPWpGaD
Minocycline—MMP9—Developmental Biology—KRAS—thyroid cancer	3.28e-05	0.000188	CbGpPWpGaD
Minocycline—VEGFA—Hemostasis—NRAS—thyroid cancer	3.25e-05	0.000186	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—CDK1—thyroid cancer	3.07e-05	0.000176	CbGpPWpGaD
Minocycline—CYCS—Metabolism—PTEN—thyroid cancer	3.04e-05	0.000174	CbGpPWpGaD
Minocycline—CASP1—Immune System—HRAS—thyroid cancer	3e-05	0.000172	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—BRAF—thyroid cancer	2.91e-05	0.000167	CbGpPWpGaD
Minocycline—IL1B—Immune System—PTEN—thyroid cancer	2.87e-05	0.000164	CbGpPWpGaD
Minocycline—VEGFA—Developmental Biology—KRAS—thyroid cancer	2.85e-05	0.000163	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—NRG1—thyroid cancer	2.84e-05	0.000163	CbGpPWpGaD
Minocycline—VEGFA—Hemostasis—KRAS—thyroid cancer	2.8e-05	0.00016	CbGpPWpGaD
Minocycline—MMP9—Developmental Biology—HRAS—thyroid cancer	2.79e-05	0.00016	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—PPARG—thyroid cancer	2.73e-05	0.000156	CbGpPWpGaD
Minocycline—CASP1—Immune System—AKT1—thyroid cancer	2.64e-05	0.000152	CbGpPWpGaD
Minocycline—IL1B—Immune System—NRAS—thyroid cancer	2.56e-05	0.000147	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—TERT—thyroid cancer	2.55e-05	0.000146	CbGpPWpGaD
Minocycline—VEGFA—Hemostasis—TP53—thyroid cancer	2.49e-05	0.000142	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—NRG1—thyroid cancer	2.46e-05	0.000141	CbGpPWpGaD
Minocycline—MMP9—Developmental Biology—AKT1—thyroid cancer	2.46e-05	0.000141	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—HIF1A—thyroid cancer	2.44e-05	0.00014	CbGpPWpGaD
Minocycline—VEGFA—Developmental Biology—HRAS—thyroid cancer	2.42e-05	0.000139	CbGpPWpGaD
Minocycline—VEGFA—Hemostasis—HRAS—thyroid cancer	2.38e-05	0.000136	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—TERT—thyroid cancer	2.21e-05	0.000127	CbGpPWpGaD
Minocycline—IL1B—Immune System—KRAS—thyroid cancer	2.2e-05	0.000126	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—PTGS2—thyroid cancer	2.15e-05	0.000123	CbGpPWpGaD
Minocycline—VEGFA—Developmental Biology—AKT1—thyroid cancer	2.14e-05	0.000123	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—CCND1—thyroid cancer	2.12e-05	0.000122	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—HIF1A—thyroid cancer	2.12e-05	0.000121	CbGpPWpGaD
Minocycline—VEGFA—Hemostasis—AKT1—thyroid cancer	2.1e-05	0.00012	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—PTEN—thyroid cancer	2.05e-05	0.000117	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—BRAF—thyroid cancer	2.02e-05	0.000116	CbGpPWpGaD
Minocycline—IL1B—Immune System—HRAS—thyroid cancer	1.87e-05	0.000107	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—PTEN—thyroid cancer	1.87e-05	0.000107	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—NRAS—thyroid cancer	1.83e-05	0.000105	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—BRAF—thyroid cancer	1.75e-05	0.0001	CbGpPWpGaD
Minocycline—CYCS—Metabolism—AKT1—thyroid cancer	1.75e-05	0.0001	CbGpPWpGaD
Minocycline—IL1B—Immune System—AKT1—thyroid cancer	1.65e-05	9.47e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—KRAS—thyroid cancer	1.57e-05	9.01e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—CCND1—thyroid cancer	1.47e-05	8.44e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—PTEN—thyroid cancer	1.42e-05	8.15e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—TP53—thyroid cancer	1.4e-05	8.01e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—HRAS—thyroid cancer	1.34e-05	7.66e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—CCND1—thyroid cancer	1.28e-05	7.33e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—NRAS—thyroid cancer	1.27e-05	7.27e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—PTEN—thyroid cancer	1.23e-05	7.07e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—AKT1—thyroid cancer	1.18e-05	6.76e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—NRAS—thyroid cancer	1.1e-05	6.31e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—KRAS—thyroid cancer	1.09e-05	6.26e-05	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—AKT1—thyroid cancer	1.08e-05	6.18e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—TP53—thyroid cancer	9.71e-06	5.56e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—KRAS—thyroid cancer	9.48e-06	5.43e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—HRAS—thyroid cancer	9.28e-06	5.32e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—TP53—thyroid cancer	8.43e-06	4.83e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—AKT1—thyroid cancer	8.2e-06	4.7e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—HRAS—thyroid cancer	8.06e-06	4.62e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—AKT1—thyroid cancer	7.12e-06	4.08e-05	CbGpPWpGaD
